Timothy R. Aksamit, MD serves as the Bronchiectasis and NTM Medical Director of the COPD Foundation. He oversees bronchiectasis and NTM projects and studies from a clinical perspective, serves as principal investigator, and advises on research strategy, partnership integration, and the development of grant proposals. He serves as author and subject matter expert to educate patients, health care professionals, caregivers, and media on the Foundation’s work and research findings on chronic lung conditions.
Dr. Aksamit is also a Consultant and Associate Professor in the Pulmonary Disease and Critical Care Medicine division of Mayo Clinic, Rochester, MN, where he serves as the Mayo Mycobacterial and Bronchiectasis Clinic Director. Prior to accepting his position as Bronchiectasis and NTM Medical Director at the COPD Foundation, Dr. Aksamit served in a voluntary capacity as Chair of the U.S. Bronchiectasis and NTM Research Registry Consortium for several years. His service as Chair of the Consortium was critical to expanding the Registry and leveraging it to further research in the field, resulting in several published manuscripts and abstracts.
Dr. Aksamit received his undergraduate degree in chemistry from the University of Illinois in Urbana, IL and his medical degree from Northwestern University in Chicago, IL. He received his medical training in internal medicine, pulmonary, and critical care medicine at the University of Iowa in Iowa City, where he also served as Chief Resident. Before joining the staff at Mayo Clinic in 1998, Dr. Aksamit completed research at Hammersmith Hospital in London, U.K. He will continue his work with the Mayo Clinic while supporting the mission of the COPD Foundation and the Bronchiectasis and NTM Initiative.